Enanta Pharma (ENTA) Misses Q1 EPS by 8c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. AMGN
3. BKNG
4. DOX
5. DUOL
6. ANET
7. SWKS
8. SPY
9. XYZ
10. FISV

Go back to Enanta Pharma (ENTA) Misses Q1 EPS by 8c

Enanta Pharmaceuticals to Present at Two Upcoming Investor Conferences

February 6, 2017 4:01 PM EST

Presentations to be Webcast on Feb. 15 and February 22

WATERTOWN, Mass.--(BUSINESS WIRE)-- Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, will present at each of the following investor conferences:

February 15, 2:30 p.m. ET LEERINK Partners 6th Annual Global Healthcare Conference, New York... More